Widely used:Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$13,903 Mln
P/E Ratio
22.62
P/B Ratio
0.83
Industry P/E
--
Debt to Equity
0.75
ROE
0.05 %
ROCE
2.1 %
Div. Yield
2.73 %
Book Value
49.68
EPS
1.83
CFO
€23,696.74 Mln
EBITDA
€26,482.27 Mln
Net Profit
€10,750.53 Mln
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Fresenius Medical Care AG - ADR
| 5.04 | -1.98 | 2.63 | 15.72 | -10.61 | -8.33 | -5.67 |
|
BSE Sensex
| 2.39 | 4.18 | 4.86 | 8.78 | 11.89 | 20.62 | 11.13 |
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
|
|
|---|---|---|---|---|---|---|---|
|
Fresenius Medical Care AG - ADR
| 8.62 | 27.48 | -49.66 | -21.90 | 12.84 | 13.71 | -38.20 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
|
BSE Sensex
| 8.10 | 18.74 | 4.44 | 21.99 | 15.75 | 14.38 | 5.87 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
3Y Avg -- 5Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a... network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Address: Else-Kröner-Strasse 1, Bad Homburg, Germany, 61352 Read more
CEO & Chair of Management Board of Fresenius Med. Care Mgmt AG
Ms. Helen Giza
Chair of Management Board & CEO
Ms. Helen Giza
Headquarters
Bad Homburg
Website
Our rating system has guided millions of investors in the past 20 years.
The total asset value of Fresenius Medical Care AG - ADR stood at $ 33,567 Mln as on 31-Dec-24
The share price of Fresenius Medical Care AG - ADR is $23.78 (NYSE) as of 23-Apr-2025 13:32 EDT. Fresenius Medical Care AG - ADR has given a return of -10.61% in the last 3 years.
Fresenius Medical Care AG - ADR has a market capitalisation of $ 13,903 Mln as on 22-Apr-2025. As per Value Research classification, it is a company.
The P/E ratio of Fresenius Medical Care AG - ADR is 22.62 times as on 22-Apr-2025.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Fresenius Medical Care AG - ADR and enter the required number of quantities and click on buy to purchase the shares of Fresenius Medical Care AG - ADR.
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure. It also develops, manufactures, and distributes various health care products, including polysulfone dialyzers, hemodialysis machines, peritoneal dialysis cyclers, peritoneal dialysis solutions, hemodialysis concentrates, solutions and granulates, bloodlines, renal pharmaceuticals, systems for water treatment, and acute cardiopulmonary and apheresis products. In addition, the company develops, acquires, and in-licenses renal pharmaceuticals; offers renal medications and supplies to patients at homes or to dialysis clinics; and provides vascular, cardiovascular, endovascular specialty, vascular care ambulatory surgery center, physician nephrology, ambulant treatment, and other services. The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics, as well as through local sales forces, independent distributors, dealers, and sales agents. Fresenius Medical Care AG was incorporated in 1996 and is headquartered in Bad Homburg, Germany. Address: Else-Kröner-Strasse 1, Bad Homburg, Germany, 61352
The CEO & director of Ms. Helen Giza. is Fresenius Medical Care AG - ADR, and CFO & Sr. VP is Ms. Helen Giza.
There is no promoter pledging in Fresenius Medical Care AG - ADR.
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|
| Fresenius Medical Care AG - ADR | Ratios |
|---|---|
|
Return on equity(%)
|
3.82
|
|
Operating margin(%)
|
7.57
|
|
Net Margin(%)
|
2.78
|
|
Dividend yield(%)
|
--
|
No, TTM profit after tax of Fresenius Medical Care AG - ADR was $0 Mln.
$-0.21
(
